Literature DB >> 4668635

Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.

R B Royds.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4668635      PMCID： PMC1666070     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  2 in total

1.  A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS.

Authors:  G A ROSE; W W HOLLAND; E A CROWLEY
Journal:  Lancet       Date:  1964-02-08       Impact factor: 79.321

2.  Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.

Authors:  B J Alps; E S Johnson; A B Wilson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739
  2 in total
  2 in total

1.  Double blind controlled trial of indoramin in the treatment of essential hypertension.

Authors:  D T Dollery; D G George; P J Lewis
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

2.  The effect of indoramin on peripheral blood flow.

Authors:  R B Royds; J D Lockhart
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.